Karen Madden

Karen Madden

Director/Miembro de la Junta en JOHN WILEY & SONS, INC. .

Fortuna: - $ al 31/05/2026

57 años
Consumer Services
Commercial Services
Health Technology

Perfil

Dr. Karen N.
Madden
is an Independent Director at John Wiley & Sons, Inc., a Head-Canada Life Science Business at Merck KGaA and a Chief Technology Officer & Senior Vice President at EMD Millipore Corp.
She is on the Board of Directors at John Wiley & Sons, Inc., Analytical Life Science & Diagnostics Association, Greater Boston Chamber of Commerce and The New England Council, Inc. Dr. Madden was previously employed as a Principal by SGX Pharmaceuticals, Inc. and a SVP-Corporate Development & External Research by VisEn Medical, Inc. She received her undergraduate degree from Boston University, a graduate degree from the University of Pennsylvania and a doctorate degree from Rutgers State University of New Jersey.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
23/04/2026 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Karen Madden

EmpresasCargoInicio
JOHN WILEY & SONS, INC. Director/Miembro de la Junta 28/02/2025
MERCK KGAA Corporate Officer/Principal 01/01/2022
Director Técnico/Científico/I+D -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Analytical Life Science & Diagnostics Association
Director/Miembro de la Junta -

Antiguos cargos conocidos de Karen Madden.

EmpresasCargoFin
Corporate Officer/Principal 26/07/2013
Corporate Officer/Principal -
Ver el detalle de la experiencia de Karen Madden.

Formación de Karen Madden.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

89

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Commercial Services

Consumer Services

Health Technology

Health Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Analytical Life Science & Diagnostics Association

Commercial Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN